Filtration methodologies for the clarification and concentration of human mesenchymal stem cells

Journal of Membrane Science

Volumn 478, Issue , 2015, Pages 117-129

  Cunha, Bárbara ^a,b   Peixoto, Cristina ^a,b   Silva, Marta M ^a,b   Carrondo, Manuel J T ^b,c   Serra, Margarida ^a,b   Alves, Paula M ^a,b  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^b INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLÓGICA   (Portugal)

^c UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

Cell concentration; Downstream processing; Human mesenchymal stem cells; Microcarriers; Tangential flow filtration

Indexed keywords

CELL CULTURE; CELLS; CLARIFICATION; CLARIFIERS; CYTOLOGY; FILTRATION; POLYPROPYLENES; POLYSULFONES; PORE SIZE; QUALITY CONTROL; RECOVERY; STEM CELLS; SUSPENSIONS (FLUIDS);

CELL CONCENTRATIONS; DOWNSTREAM-PROCESSING; HUMAN MESENCHYMAL STEM CELLS; MICROCARRIERS; TANGENTIAL FLOW FILTRATIONS;

MOLECULAR BIOLOGY;

POLYPROPYLENE; POLYSULFONE;

ARTICLE; CELL SEPARATION; CELL SUSPENSION; CELL VIABILITY; CONTROLLED STUDY; FLOW; GOOD MANUFACTURING PRACTICE; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; SHEAR RATE;

EID: 84921482513     PISSN: 03767388     EISSN: 18733123     Source Type: Journal    
DOI: 10.1016/j.memsci.2014.12.041     Document Type: Article

References (37)

1. Iyer S.S., Rojas M. Anti-inflammatory effects of mesenchymal stem cells: novel concept for future therapies. Expert Opin. Biol. Ther. 2008, 8:569-581.
2. Haynesworth S.E., Baber M.A., Caplan A.I. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J. Cell. Physiol. 1996, 166:585-592.
3. Murphy M.B., Moncivais K., Caplan A.I. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp. Mol. Med. 2013, 45:54-70.
4. Mason C., Dunnill P. Quantities of cells used for regenerative medicine and some implications for clinicians and bioprocessors. Regen. Med. 2009, 4:153-157.
5. Chen A.K.-L., Reuveny S., Oh S.K.W. Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: achievements and future direction. Biotechnol. Adv. 2013, 31:1032-1046.
6. Serra M., Brito C., Correia C., Alves P.M. Process engineering of human pluripotent stem cells for clinical application. Trends Biotechnol. 2012, 30:350-359.
7. Pattasseril J., Varadaraju H., Lock L., Rowley J.A., Rowley J.A. Downstream technology landscape for large-scale therapeutic cell processing. Bio. Process Int. 2013, 3:38-46.
8. Lilova K. Process development and scale-up of an allogeneic cell therapy product. Oral Presentation at Scale-Up and Manufacturing of Cell-Based Therapies III 2014.
9. Kehoe D. Scalable expansion and harvest solutions for allogeneic stem cells. Oral Presentation at Scale-Up and Manufacturing of Cell-Based Therapies III 2014.
10. Nienow A.W., Rafiq Q.A., Coopman K., Hewitt C. A potentially scalable method for the harvesting of hMSCs from microcarriers. Biochem. Eng. J. 2014, 85:79-88.
11. van Reis R., Leonard L.C., Hsu C.C., Builder S.E. Industrial scale harvest of proteins from mammalian cell culture by tangential flow filtration. Biotechnol. Bioeng. 1991, 38:413-422.
12. Vicente T., Peixoto C., Carrondo M.J.T., Alves P.M. Purification of recombinant baculoviruses for gene therapy using membrane processes. Gene Ther. 2009, 16:766-775.
13. Maiorella B., Dorin G., Carion A. Crossflow microfiltration of animal cells. Biotechnol. Bioeng. 1991, 37:121-126.
14. Saha K., Lin Y.C., Wong P.K. A simple method for obtaining highly viable virus from culture supernatant. J. Virol. Methods 1994, 46:349-352.
15. Clincke M.-F., Mölleryd C., Zhang Y., Lindskog E., Walsh K., Chotteau V. Very high density of CHO cells in perfusion by ATF or TFF in WAVE bioreactor™. Part I. effect of the cell density on the process. Biotechnol. Prog. 2013, 29:754-767.
16. Cunha B., Serra M., Peixoto C., Silva M., Carrondo M.J.T., Alves P.M. Designing clinical-grade integrated strategies for the downstream processing of human mesenchymal stem cells. BMC Proc. 2013, 7:103-105.
17. Charcosset C. Principles on membrane and membrane processes. Membrane Processes in Biotechnology and Pharmaceutics 2012, 1-30. Elsevier, Oxford. C. Charcosset (Ed.).
18. Cheryan M. Ultrafiltration and Microfiltration Handbook 1998, Technomic Publishing Company, Inc., Pennsylvania. second ed.
19. Son Y. Determination of shear viscosity and shear rate from pressure drop and flow rate relationship in a rectangular channel. Polymer 2007, 48:632-637.
20. Jones K.H., Senft J.A. An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide. J. Histochem. Cytochem. 1985, 33:77-79.
21. Fotakis G., Timbrell J.A. In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol. Lett. 2006, 160:171-177.
22. Vassault A. Lactate dehydrogenase: UV-method with pyruvate and NADH. Methods of Enzymatic Analysis 1983, 118-126. John Wiley & Sons, New York. H.U. Bergmeyer, M. Grassl (Eds.).
23. Santos F.D., Andrade P.Z., Abecasis M.M., Gimble J.M., Chase L.G., Campbell A.M., et al. Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions. Tissue Eng. Part C 2011, 17:1201-1210.
24. Alt E., Yan Y., Gehmert S., Song Y.-H., Altman A., Gehmert S., et al. Fibroblasts share mesenchymal phenotypes with stem cells, but lack their differentiation and colony-forming potential. Biol. Cell. 2011, 103:197-208.
25. Kretzmer G. Influence of stress on adherent cells. Adv. Biochem. Eng. Biotechnol. 2000, 67:123-137.
26. Dong J.-D., Gu Y.-Q., Li C.-M., Wang C.-R., Feng Z.-G., Qiu R.-X., et al. Response of mesenchymal stem cells to shear stress in tissue-engineered vascular grafts. Acta Pharmacol. Sin. 2009, 30:530-536.
27. Yourek G., McCormick S.M., Mao J.J., Reilly G.C. Shear stress induces osteogenic differentiation of human mesenchymal stem cells. Regen. Med. 2010, 5:713-724.
28. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
29. Zydney A.L., Kuriyel R. High-performance tangential flow filtration for protein separations. Downstream Processing of Proteins: Methods and Protocols 2000, 35-46. Humana Press, Totowa, NJ. M.A. Desai (Ed.).
30. Miller D.J., Paul D.R., Freeman B.D. A crossflow filtration system for constant permeate flux membrane fouling characterization. Rev. Sci. Instrum. 2013, 84:035003.
31. ®) therapy. Stem Cells Cloning: Adv. Appl. 2011, 4:61-72.
32. van Reis R., Zydney A. Bioprocess membrane technology. J. Memb. Sci. 2007, 297:16-50.
33. Castilho L.R., Medronho R.A. Cell retention devices for suspended-cell perfusion cultures. Advances in Biochemical Engineering/Biotechnology 2002, 129-169. Springer, Berlin Heidelberg, Berlin. T. Scheper, S. Belkin, P.M. Doran, I. Endo, M.B. Gu, W.S. Hu (Eds.).
34. Walter J.K., Jin Z., Jornitz M.W., Gottschalk U. Membrane separations. Protein Purification: Principles, High Resolution Methods, and Applications 2011, 279-317. John Wiley & Sons, Inc, New Jersey. third ed. J.-C. Janson (Ed.).
35. Wakeman R.J., Williams C.J. Additional techniques to improve microfiltration. Sep. Purif. Technol. 2002, 26:3-18.
36. Vickroy B., Lorenz K., Kelly W. Modeling shear damage to suspended CHO cells during cross-flow filtration. Biotechnol. Prog. 2007, 23:194-199.
37. Sonowal H., Kumar A., Bhattacharyya J., Gogoi P.K., Jaganathan B.G. Inhibition of actin polymerization decreases osteogeneic differentiation of mesenchymal stem cells through p38 MAPK pathway. J. Biomed. Sci. 2013, 20:71-81.